Evidence map›Paper›PMID 20432235›Full record

ArticleEuropean journal of immunology2010

Generation of robust CD8+ T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopes.

Keri L Schaubert, David A Price, Janelle R Salkowitz, Andrew K Sewell, John Sidney, Tedi E Asher, Sylvie E Blondelle, Sharon Adams, Francesco M Marincola, Aviva Joseph and 10 more

Open access · greenAbstract read
In one paragraph

Article in European journal of immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Rapid, efficient functional characterization and recovery of HIV-specific human CD8+ T cells using microengraving.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 2 countries.

Keri L SchaubertDepartment of Biological Sciences and Border Biomedical Research Institute, University of Texas at El Paso, El Paso, TX, USA.
David A Price
Janelle R Salkowitz
Andrew K Sewell
John Sidney
Tedi E Asher
Sylvie E Blondelle
Sharon Adams
Francesco M Marincola
Aviva Joseph
Alessandro Sette
Daniel C Douek
Velpandi Ayyavoo
Walter Storkus
Ming-Ying Leung
Hwee L Ng
Otto O Yang
Harris Goldstein
Darcy B Wilson
June Kan-Mitchell
The University of Texas at El Paso · USNational Institute of Allergy and Infectious Diseases · USAlbert Einstein College of Medicine · USLa Jolla Institute for Immunology · USNational Institutes of Health · USTorrey Pines Institute For Molecular Studies · USUniversity of California, Los Angeles · USCardiff University · GBUniversity of Pittsburgh · USUPMC Hillman Cancer Center · US

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
TOXICOLOGY PROJECTG12RR008124 · NCRR · UNIVERSITY OF TEXAS EL PASO · PI AGUILERA, RENATO J · 1992 to 2011
$20.8M
T Cell Immune Responses To HIV And Other PathogensZIAAI005033 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DOUEK, DANIEL CESAR · 2009 to 2025
$11.4M
InflammationZIAAI005031 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DOUEK, DANIEL CESAR · 2009 to 2024
$5.9M
Optimizing Gag CTL Epitopes to Improve ImmunogenicityR01AI064069 · NIAID · WAYNE STATE UNIVERSITY · PI KAN-MITCHELL, JUNE · 2006 to 2010
$2.8M
Mapping novel subdominant B*5701 epitopes in conserved regions of the HIV proteomR01AI077413 · NIAID · UNIVERSITY OF TEXAS EL PASO · PI KAN-MITCHELL, JUNE · 2008 to 2011
$2.5M
Mimic Peptides of HIV-1 Epitopes as VaccinesR44DA015212 · NIDA · MIXTURE SCIENCES, INC. · PI WILSON, DARCY B · 2004 to 2005
$1.5M
Immunogenic epitopes of rare HIV mutants as vaccinesR43DA021175 · NIDA · MIXTURE SCIENCES, INC. · PI BLONDELLE, SYLVIE E · 2005 to 2006
$600k
Immunogenetics of Vaccine TherapyZIACL002115 · CLC · CLINICAL CENTER · PI MARINCOLA, FRANCESCO M · 2009 to 2010
$0k
Immunogenetic Study of Infectious Diseases and CancerZIACL002118 · CLC · CLINICAL CENTER · PI MARINCOLA, FRANCESCO M · 2009 to 2012
$0k
Medical Research Council G0501963NCATS NIH HHS UL1 TR000005NCRR NIH HHS 5G12RR008124NCRR NIH HHS G12 RR008124NIAID NIH HHS R01 AI064069NIAID NIH HHS R01-AI064069NIAID NIH HHS R01 AI077413NIAID NIH HHS R01-AI77413NIDA NIH HHS R43 DA021175NIDA NIH HHS R43DA021175NIDA NIH HHS R44 DA015212NIDA NIH HHS R44DA015212
6 · The paper itself

Abstract

HLA-A 0201-restricted virus-specific CD8(+) CTL do not appear to control HIV effectively in vivo. To enhance the immunogenicity of a highly conserved subdominant epitope, TV9 (TLNAWVKVV, p24 Gag(19-27)), mimotopes were designed by screening a large combinatorial nonapeptide library with TV9-specific CTL primed in vitro from healthy donors. A mimic peptide with a low binding affinity to HLA-A 0201, TV9p6 (KINAWIKVV), was studied further. Parallel cultures of in vitro-primed CTL showed that TV9p6 consistently activated cross-reactive and equally functional CTL as measured by cytotoxicity, cytokine production and suppression of HIV replication in vitro. Comparison of TCRB gene usage between CTL primed from the same donors with TV9 or TV9p6 revealed a degree of clonal overlap in some cases and an example of a conserved TCRB sequence encoded distinctly at the nucleotide level between individuals (a "public" TCR); however, in the main, distinct clonotypes were recruited by each peptide antigen. These findings indicate that mimotopes can mobilize functional cross-reactive clonotypes that are less readily recruited from the naïve T-cell pool by the corresponding WT epitope. Mimotope-induced repertoire diversification could potentially override subdominance under certain circumstances and enhance vaccine-induced responses to conserved but poorly immunogenic determinants within the HIV proteome.

Indexed as

AIDS VaccinesCD8-Positive T-LymphocytesCell ProliferationClone CellsConserved SequenceDNAEpitope MappingHIV-1HIV Core Protein p24HLA-A2 AntigenHLA-A AntigensHumansPeptide FragmentsPeptide LibraryProtein BindingReceptors, Antigen, T-Cell, alpha-betaAIDS VaccinesDNAHIV Core Protein p24HLA-A*02:01 antigenHLA-A2 AntigenHLA-A Antigensp24 protein, Human Immunodeficiency Virus Type 1Peptide FragmentsPeptide LibraryReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID20432235
PMCPMC3086652
OpenAlexW2074590030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.